2025 Measures

With the CEDR Qualified Clinical Data Registry (QCDR) option in 2025, clinicians may choose to report the following QCDR Measures & MIPS Measures to receive credit for MIPS quality reporting. Note: A link to the 2024 measures is available below.

QCDR Measures Supported

Scroll → to View

ID
Description
Domain
Type
High Priority
ACEP22
Appropriate Emergency Department Utilization of CT for Pulmonary Embolism
Efficiency & Cost Reduction
Process
ACEP25
Tobacco Use: Screening and Cessation Intervention for Patients with Asthma and COPD
Community/Population Health
Process
ACEP30
Septic shock outcomes: Lactate clearance rate of greater than equal to 10%
Effective Clinical Care
Outcome
ACEP31
Appropriate Foley Catheter Use in the Emergency Department
Patient Safety
Process
ACEP48
Sepsis diagnosis and management: Lactate Level Measurement, Antibiotics Ordered, and Fluid Resuscitation
Effective Clinical Care
Process
ACEP50
ED Median Time from ED arrival to ED departure for all Adult Patients
Person and Caregiver Centered Experience and Outcomes
Outcome
ACEP51
ED Median Time from ED arrival to ED departure for all Pediatric ED Patients
Person and Caregiver Centered Experience and Outcomes
Outcome
ACEP52
Appropriate Emergency Department Utilization of Lumbar Spine Imaging for Atraumatic Low Back Pain
Efficiency and Cost Reduction
Process
ACEP53
Appropriate Use of Imaging for Recurrent Renal Colic
Efficiency and Cost Reduction
Process
ACEP54
Appropriate Utilization of Focused Assessment with Sonography for Trauma (FAST) Exam in the Emergency Department
Efficiency and Cost Reduction
Process
ACEP56
Follow-Up Care Coordination Documented in Discharge Summary
Communication & Care Coordination
Process
ACEP59
Chest Pain – Avoidance of admission for adult patients with low-risk chest pain.
Effective Clinical Care
Outcome
ACEP60
Syncope – Avoidance of admission for adult patients with low-risk syncope
Effective Clinical Care
Outcome
ACEP61
Avoidance of Chest X-ray in pediatric patients with Asthma, Bronchiolitis or Croup.
Effective Clinical Care
Process
ACEP62
Avoidance of Opioid therapy for dental pain.
Effective Clinical Care
Process
ACEP63
Avoidance of Acute High-Risk Prescriptions in Geriatric Patients at Discharge.
Effective Clinical Care
Process
ACEP64
Avoidance of admission for adult patients in Emergency Department with low-risk Deep Vein Thrombosis (DVT).
 
Outcome
ACEP65
Appropriate Utilization of Imaging in rAAA (ruptured Abdominal Aortic Aneurysm) patients in Emergency Department.
 
Process
ACEP66
Co-testing for HIV in high-risk patients in Emergency Department who are being tested for other sexually transmitted infections (STI) (Gonorrhea, Chlamydia, Syphilis or Trichomonas).
 
Process
ACEP67
Avoidance of Admission for Atrial Fibrillation
 
Process
ACEP68
Point-of-care ultrasound (POCUS) in Cardiac Arrest.
 
Process
ACEP69
Blood Pressure Control Among Adult ED Patients with Nontraumatic Intracranial Hemorrhage
 
Process
ACEP70
Syphilis testing among ED patients with a positive pregnancy test.
 
Process
ACEP71
Emergency Medicine: Coagulation Studies in Patients Presenting to the Emergency Department with No Coagulopathy or Bleeding
 
Process
ECPR46
Avoidance of Opiates for Low Back Pain or Migraines
Effective Clinical Care
Process
ECPR51
Discharge Prescription of Naloxone after Opioid Poisoning or Overdose
Effective Clinical Care
Process
HCPR20
Clostridium Difficile – Risk Assessment and Plan of Care
 
Process
HCPR24
Appropriate Utilization of Vancomycin for Cellulitis
 
Process
THEPQR1
High Intensity Statin Prescribed for Acute and Subacute Ischemic Stroke and Transient Ischemic Attack (TIA).
 
Process
THEPQR2
Discontinuation of Proton Pump Inhibitors for patients who do not meet criteria for long-term utilization.
 
Process

QPP Measures Supported

Scroll → to View

ID
Description
Domain
Type
High Priority
QPP5
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
Effective Clinical Care
Process
QPP8
Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
Effective Clinical Care
Process
QPP47
Advance Care Plan
Communication & Care Coordination
Process
QPP65
Appropriate Treatment for Children with Upper Respiratory Infection (URI)
Efficiency & Cost Reduction
Process
QPP66
Appropriate Testing for Children with Pharyngitis
Efficiency & Cost Reduction
Process
QPP116
Avoidance of Antibiotic Treatment in Adults With Acute Bronchitis
Efficiency & Cost Reduction
Process
QPP130
Documentation of Current Medications in the Medical Record
Patient Safety
Process
QPP134
Preventive Care and Screening: Screening for Depression and Follow-Up Plan
 
Process
QPP187
Stroke and Stroke Rehabilitation: Thrombolytic Therapy (tPA)
Effective Clinical Care
Process
QPP317
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
Community - Population Health
Process
QPP326
Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy
Effective Clinical Care
Process
QPP331
Adult Sinusitis: Antibiotic Prescribed for Acute Sinusitis (Overuse)
Efficiency and Cost Reduction
Process
QPP332
Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patient with Acute Bacterial Sinusitis (Appropriate Use)
Efficiency and Cost Reduction
Process
QPP415
Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older
Efficiency and Cost Reduction
Efficiency
QPP416
Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 Years
Efficiency and Cost Reduction
Efficiency
QPP431
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling
 
Process
QPP487
Screening for Social Drivers of Health
 
Process
QPP498
Connection to Community Service Provider
 
Process

For more information contact us today.